Blueskeye AI
PrivateLast Round
Accelerator
Apr 9, 2025
Total Funding Raised
$4.19M
Company Overview
Blueskeye AI operates in Healthcare & Life Sciences and is based in Nottingham. Its latest recorded funding round was a Grant round in September 2024.
Blueskeye AI is a healthtech company that develops artificial intelligence for face and voice analysis to measure mental health and well-being.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical AI, Computer Vision, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Blueskeye AI Comparables
Compare Blueskeye AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deliberate AI | 86% | |
| Mobio Interactive | 83% | |
| Kintsugi | 78% |
For institutional investors. Book with your work email.
Blueskeye AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 9, 2025 | ||||
| Grant | Sep 5, 2024 | ||||
| Grant | Mar 1, 2024 | ||||
| Grant | Feb 1, 2023 | ||||
| Seed | Oct 18, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Blueskeye AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centre for Connected and Autonomous Vehicles | Grant |
| Foresight Group Holdings Limited | Seed |
| Praetura Ventures | Seed |
| Zenzic | Grant |
| European Regional Development Fund | Grant |
| Minerva Business Angels | Seed |
| Innovate UK | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 5, 2024
$130K grant received from Centre for Connected and Autonomous Vehicles and Zenzic.
- Oct 18, 2022
$3.86M round led by XTX Ventures.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 24, 2026
Researchers from the University of Nottingham and Nottinghamshire Healthcare NHS Foundation Trust work with Blueskeye to develop an app that tracks mood and behaviour, analyzes facial expressions, speech and movements, and flags depression risk in pregnant women and new mothers; the study is in its final stages and aims to finish in Oct '26 in the United Kingdom.
For institutional investors. Book with your work email.
Blueskeye AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Blueskeye AI's valuation, stock price, and market status.
Is Blueskeye AI a public or private company?
Blueskeye AI is a private company.
What is the current stock price of Blueskeye AI?
Blueskeye AI is a private company, so its shares have no public market price. Caplight tracks Blueskeye AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Blueskeye AI worth (valuation)?
Valuation information for Blueskeye AI is not publicly available.
Can I buy Blueskeye AI stock?
Blueskeye AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Blueskeye AI's last funding round?
Blueskeye AI's most recent funding round was Accelerator on April 9, 2025.
Who are the main investors in Blueskeye AI?
Key investors in Blueskeye AI include XTX Ventures.
Will Blueskeye AI IPO soon?
No public IPO plans have been announced for Blueskeye AI.
How can I track Blueskeye AI secondary market activity?
Caplight tracks bids, offers, and trades in Blueskeye AI's shares on secondary markets.